Virtual screening of gut microbiome bacteriocins as potential inhibitors of stearoyl-CoA desaturase 1 to regulate adipocyte differentiation and thermogenesis to combat obesity-Reference-Cited by-同舟云学术

Virtual screening of gut microbiome bacteriocins as potential inhibitors of stearoyl-CoA desaturase 1 to regulate adipocyte differentiation and thermogenesis to combat obesity

Published:2023-01-16 Issue: Volume: Page:1-11
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Kumari Rekha¹,Singhvi Nirjara²,Sharma Poonam³,Choudhury Chinmayee⁴,Shakya Rashmi⁵

Affiliation:

1. Molecular Microbiology and Bioinformatics Laboratory, Department of Zoology, Miranda House, University of Delhi, Delhi, India

2. School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand, India

3. Department of Zoology, Gargi College, University of Delhi, Delhi, India

4. Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, India

5. Department of Botany, Miranda House, University of Delhi, Delhi, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2167121

Reference63 articles.

1. Beige Adipocyte as the Flame of White Adipose Tissue: Regulation of Browning and Impact of Obesity

2. Bacteriocin PJ4 from probiotic lactobacillus reduced adipokine and inflammasome in high fat diet induced obesity

3. Toward the estimation of the absolute quality of individual protein structure models

4. Functions and emerging applications of bacteriocins

5. Importance of gut microbiota in obesity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of postbiotics for the treatment of metabolic disorders;Drug Discovery Today;2024-04

2. White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues;Biochemical Pharmacology;2024-02

3. Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach;Medical Science Monitor;2024-01-22

4. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors;Biomedicine & Pharmacotherapy;2024-01